TrialThorax2015

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial.

Peter A Frith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.